Page contentsKey factsDecisionKey facts Active Substance Dronabinol Therapeutic area Neurology Decision number P/0344/2020 PIP number EMEA-000643-PIP02-20 Pharmaceutical form(s) Oral solution Condition(s) / indication(s) Treatment of spasticity Route(s) of administration Oral use Contact for public enquiries Bionorica Ethics GmbHE-mail: info@bionorica-ethics.deTel. +49 91812317490 Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 09/09/2020DecisionP/0344/2020 : EMA decision of 9 September 2020 on the granting of a product specific waiver for dronabinol (EMEA-000643-PIP02-20)AdoptedReference Number: EMA/430119/2020 English (EN) (259.34 KB - PDF)First published: 06/07/2021ViewShare this page